Postoperative Antibiotics in Head and Neck Oncology

Rationale and Wound Classification

• Aerobic Gram-positive cocci (Streptococci, Staphylococci)
• Anaerobes (Bacteroides, Fusobacterium, Peptostreptococcus)
• Aerobic Gram-negative rods (Pseudomonas, Klebsiella, Enterobacter)
• Polymicrobial infection is the rule, not the exception
• Candida is frequently cultured but almost always represents colonization, not true infection

Antibiotic Regimens

1. Ampicillin-Sulbactam (First-line, USA)

• Dose: 3 g (ampicillin 2 g + sulbactam 1 g) IV preoperatively, then every 6 hours postoperatively
• Covers Gram-positives, Gram-negatives, and anaerobes
• Widely used in the US for major head and neck cases with mucosal entry
• EU equivalent: Amoxicillin-clavulanic acid 1.2 g IV

2. Clindamycin (Alternative / Penicillin-allergic patients)

• Dose: 600-900 mg IV within 1 hour of incision, then 600 mg IV every 6-8 hours postoperatively
• Excellent anaerobic and Gram-positive coverage
• Less Gram-negative coverage - may be supplemented with metronidazole in some protocols
• Iowa Head and Neck Protocol: 600 mg IV pre-op + 4 additional doses Q6H

3. Cefazolin (± Metronidazole)

• Cefazolin alone: 2 g IV pre-op, then 1 g IV every 8 hours for up to 48 hours
• Cefazolin + Metronidazole: Cefazolin 1 g IV Q8H + Metronidazole 500-900 mg IV Q8H for a total of 6 doses each
• Metronidazole provides superior anaerobic coverage and may penetrate abscess cavities better than other agents
• This combination is commonly used for pharyngeal/laryngeal resections

4. MD Anderson Protocol (2024)

• Cefazolin 2 g IV (3 g if ≥120 kg)
• With penicillin allergy: Levofloxacin 500 mg IV + Clindamycin 600-900 mg IV (weight-dependent)
• Discontinue all antibiotics within 24 hours of first dose (standard)

Duration of Postoperative Antibiotics

• Multiple studies show no benefit of extending PAP beyond 24-48 hours postoperatively in most clean-contaminated head and neck cases (University of Iowa, PMC 2025 review)
• A 2025 PMC systematic review found: "The majority of studies show no benefit of prolonging PAP over 24 h or 48 h postoperatively"
• Despite this, many centers continue antibiotics for 7 days in practice - this is NOT evidence-based
• The 72-hour extension for bony reconstruction is extrapolated from open fracture/orthopedic protocols due to biofilm risk on osteosynthetic hardware - it lacks robust RCT-level evidence but is pragmatically accepted
• SSI rates in head and neck cancer surgery remain high (>40%) even with PAP, due to factors like malnutrition, prior chemoradiation, diabetes, and immunosuppression

Special Considerations in Head and Neck Oncology

1. Prior radiotherapy to the field (impaired wound healing, reduced vascularity)
2. Malnutrition / low albumin
3. Diabetes mellitus
4. Extended surgical duration (>4-6 hours) - consider intraoperative redosing
5. Tracheostomy (colonization with Gram-negatives including Pseudomonas)
6. Free flap reconstruction (longer procedure, exposed hardware)
7. Pharyngocutaneous fistula risk (laryngectomy cases)

• Cefazolin: redose every 3-4 hours intraoperatively, or after >1,500 mL blood loss
• Clindamycin: redose every 6 hours
• Ampicillin-sulbactam: redose every 2 hours (US) or 3-11 hours (EU)

• Clindamycin 900 mg IV + Levofloxacin 500 mg IV (MD Anderson 2024 guideline)
• Vancomycin can be substituted for Gram-positive coverage when MRSA risk is high

Procedures NOT Requiring Postoperative Antibiotics

• Thyroidectomy / parathyroidectomy (clean wound)
• Parotidectomy / submandibular gland excision (external approach only)
• Tonsillectomy (in children - high-level evidence against routine use)
• Clean neck dissection without mucosal entry
• Lateral skull base surgery (clean)

Summary

• Antibiotic Prophylaxis in Head and Neck Oncologic Surgery with Free Flap Reconstruction (PMC 2025)
• Iowa Head and Neck Protocols - Antibiotic Prophylaxis
• MD Anderson Surgical Antibiotic Prophylaxis Algorithm 2024

Important Transparency Note

1. Practices known from Indian studies conducted at tertiary cancer centres (including TMH-Parel affiliated publications)
2. The Indian context-specific considerations that shape how TMH and similar centres approach perioperative antibiotics

What Is Known About Indian Tertiary Oncology Centre Practice

Standard Regimen Used at Indian Cancer Centres (including TMH-type practice)

First-Line Regimen: Amoxicillin-Clavulanate + Metronidazole

Practical Indian Protocol (Major Clean-Contaminated H&N Oncology Surgery)

• Injection Amoxicillin-Clavulanate 1.2 g IV - given 30-60 minutes before skin incision
• Injection Metronidazole 500 mg IV - infused over 20-30 minutes pre-incision

• Inj. Amoxicillin-Clavulanate 1.2 g IV every 8 hours
• Inj. Metronidazole 500 mg IV every 8 hours
• Duration: 48-72 hours for soft-tissue cases; up to 5-7 days in practice (though not evidence-based) for:
  • Prior chemoradiotherapy to the field
  • Free flap with bony reconstruction (fibula flap, iliac crest)
  • Pharyngocutaneous fistula risk cases (total laryngectomy)
  • Heavily immunocompromised / malnourished patients

• Inj. Clindamycin 600 mg IV Q8H + Inj. Ciprofloxacin 400 mg IV Q12H

Why Indian Practice Differs from Western Protocols

The Local Microbiology Problem

• SSI rate: 8% (lower than Western reports of 20-40%, likely due to patient selection)
• Gram-negative organisms dominated: 70.5% of isolates (vs. Gram-positive in Western series)
• Polymicrobial infection in 41.6% of infected wounds
• Most common pathogens:
  • Pseudomonas aeruginosa
  • Klebsiella pneumoniae
  • Escherichia coli
  • Staphylococcus aureus (including MRSA)

Key Indian-Specific Differences

Practical Protocol Summary for Major Head and Neck Oncology Surgery (India)

PRE-OPERATIVE (30-60 min before incision):
  Inj. Amoxicillin-Clavulanate 1.2 g IV (slow infusion)
  Inj. Metronidazole 500 mg IV (over 20 min)

INTRAOPERATIVE REDOSING (if surgery >3 hours):
  Repeat Amoxicillin-Clavulanate 1.2 g IV

POST-OPERATIVE:
  Inj. Amoxicillin-Clavulanate 1.2 g IV Q8H
  Inj. Metronidazole 500 mg IV Q8H

DURATION:
  Standard clean-contaminated (primary closure): 48 hours
  Free flap (soft tissue): 48-72 hours
  Free flap (bony/fibula): 72 hours - 5 days*
  Post-chemoradiation / high risk: 5-7 days* (*institutional practice,
                                              not evidence-based)

ORAL STEP-DOWN (when tolerating orally):
  Tab. Amoxicillin-Clavulanate 625 mg BD/TDS
  Tab. Metronidazole 400 mg TDS
  For 3-5 days (completing total course)

PENICILLIN ALLERGY ALTERNATIVE:
  Inj. Clindamycin 600 mg IV Q8H
  + Inj. Ciprofloxacin 400 mg IV Q12H

Where Evidence and Indian Practice Diverge

1. High MDR organism rates and fear of treatment failure
2. High-risk patient profiles (malnutrition, tobacco use, prior RT)
3. Absence of a nationally mandated antimicrobial stewardship framework specific to oncologic H&N surgery
4. Institutional tradition and surgeon preference

What's included in the PDF: